SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
191 hedge funds and large institutions have $446M invested in Sage Therapeutics in 2025 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 59 increasing their positions, 56 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% less funds holding
Funds holding: 198 → 191 (-7)
6.14% less ownership
Funds ownership: 84.18% → 78.04% (-6.1%)
12% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 42
Holders
191
Holding in Top 10
5
Calls
$7.52M
Puts
$4.19M
Top Buyers
| 1 | +$14.6M | |
| 2 | +$12.8M | |
| 3 | +$12.5M | |
| 4 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$11.6M |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$9.87M |
Top Sellers
| 1 | -$24.3M | |
| 2 | -$24.2M | |
| 3 | -$16.5M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$16.2M |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$11M |
